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When Perception Becomes Unreal!Leslee Shaw, PHD,* Y. Chandrashekhar, MD,y Jagat Narula, MD, PHDzWe see things not as they are, but as we are.
—Source unknown (1)O ver the past decade, private and publicpayers have used a barrage of programsand policies to restrain growth and exces-
sive utilization patterns within cardiovascular imag-
ing. Dramatic cuts in payments, prior authorization
programs, and reliance on proprietary algorithms to
deﬁne appropriate use are now standard policies
to guide reimbursement for the majority of cardiovas-
cular imaging. There is a general perception among
most within the cardiovascular community that
these draconian policies to constrain growth were
born of the overuse of cardiovascular imaging. Even
a recent statement from the American College of
Cardiology focused attention on the perceptibly
high rates of cardiovascular imaging and the need
for greater evidence to guide the development of
clinical practice guidelines and appropriate use
criteria (2).
But is perception reality? In this issue of iJACC,
Farmer et al. (3) examine cardiovascular imaging uti-
lization patterns from a large registry of patients
presenting for de novo heart failure hospitalization.
What is intriguing from this report is that unexpectedly
low rates of imaging utilization were documented
for this high-risk cohort of patients with heart
failure. The ﬁrst question that must be asked is how
this could be, given all of the discussion about egre-
gious and excessive imaging utilization practices.From the *Emory Center for Clinical Cardiovascular Research Institute,
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the contents of this paper to disclose.Moreover, what happened to the old adage that imag-
ing begets more imaging? This adage is commonly
used by payers to guide coverage policies of denial
for imaging procedures. Under this principle, it is
perceived that an index procedure will open the
“ﬂoodgates” to not one but multiple cardiovascular
procedures and not just for the index episode of
care but throughout the life of the patient. Interest-
ingly, Farmer et al.’s (3) report reveals that very few
patients underwent multiple procedures. Although
one-half of patients with heart failure reasonably
underwent echocardiography, most of the other
common procedures were used in roughly 5% of
patients. Coupled with the available data on appro-
priate use with a minority of patients having inappro-
priate indications for testing (4,5), it appears that a
very different utilization pattern is emerging. This
pattern may be an excellent example of perception
driving an unreal view of the practice of cardiovascular
imaging.
Of course, the report by Farmer et al. (3) was derived
from within the Kaiser health care system and may
reﬂect varying utilization patterns than would be
observed elsewhere. However, and importantly, these
data are exactly what are needed to curb speculation
on what is driving growth in cardiovascular imaging
practices. The absence of data always fuels mis-
perceptions, and coupled with the high cost of care
for imaging services, the default position among
payers, regulators, and policy experts, not surpris-
ingly, has been one of containment, concluding that
imaging growth was undoubtedly due to overuse
rather than any other equally plausible reason,
such as growth in the number of patients needing
imaging or newer data showing an advantage of
imaging in certain conditions such as heart failure.
One metric that raises oft-repeated concerns about
cost of imaging is its dollar value increase over and
Shaw et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 7 , 2 0 1 4
Editor’s Page J U L Y 2 0 1 4 : 7 4 5 – 7
746above inﬂation; this economic index, although good
for linking wages or consumer goods, is hardly the
comprehensive benchmark for growth in medical
care. What if this perception was not true, and the
metrics were wrong? What if the need in the commu-
nity has expanded greatly as a result of the growing
prevalence of cardiac-predisposing risk factors such
as obesity, diabetes, and hypertension, leading to
incident heart failure or other cardiac symptoms?
And what if this need has not been thoroughly
documented? Of course, we are speculating, but
what is clear is that policies and regulations guiding
medical coverage and payments for cardiovascular
imaging should be guided by a clear reality of existing
practices.
Is the relentless drumbeat about the cost of
imaging and the daily Sisyphean task of getting
appropriate reimbursement driving us to the other
extreme of underutilization and inactivity, becoming
the easy way out? Could the underutilization of
imaging be a possibility in Farmer et al.’s (3) paper?
Once again, the lack of appropriate data on what is
an appropriate level of use becomes a hurdle in pro-
tecting against underutilization. A recent paper
describing the low rates of normal coronary angiog-
raphy in the U.S. Department of Veterans Affairs, a
closed system somewhat like the one in the present
paper, illustrates this dilemma (6). Although the low
rate of normal coronary arteries was interpreted as
underutilization of this diagnostic modality, one
could not be certain that these rates were appropriate
compared with possible overutilization in the com-
munity (6,7). More important, imaging before referral
to angiography reduced the chance of ﬁnding normal
arteries, suggesting that increased use of imaging in
certain situations might actually reduce the down-
stream use of inappropriate high-risk testing. More
important, although there are emerging data that
inappropriate use is associated with poorer outcomes,
there is not enough information about the conse-
quences of inadequate utilization. Undertesting is
well documented, but its impact on clinical outcomes
is less well studied, and there are thus few data to
make clinically relevant decisions about appropriate
rates of testing.
Are these data speciﬁc to the practice patterns of
closed systems such as Kaiser and the Department
of Veterans Affairs, which exert different degrees of
institutional mandates on practice? These systems
also divorce testing from compensation and thereby
take away a purported incentive to imaging (8). That
may very well be true, but the wide variation in
testing among centers within this system, similar to
the variations described amongMedicare populations,suggests only loose control of practice patterns. These
data thus might be applicable to the general patient
care practice.
As we envision the future, the denominator of
“at-risk” patients should be deﬁned on the basis of
guideline-accepted or appropriate indications for
testing using the infrastructure of electronic health
records (EHRs) currently implemented across the
country. Anyone with a rudimentary understanding
of the current state of EHRs understands that these
systems are organized largely for billing purposes,
not for easily capturing and displaying clinical
outcomes. Even with the enormous cost of these
systems, an adequate derivation of indications for
testing based on clinical practice guidelines and
appropriate use criteria indications is extremely
difﬁcult. Any health care institution trying to
demonstrate “meaningful use” would invariably ﬁnd
that demonstrating quality practices is challenging
and far from seamless given the current structure of
its EHR. Despite their promise of allowing clinical
care nirvana and ersatz answers, using EHRs to guide
quality improvement programs requires substantial
manual review and collating of data across the
health care system. In general, our EHRs exist in
silos, and connecting across imaging laboratories to
deﬁne quality practices is a daunting and labor-
intensive practice. Extracting relevant quality data
from existing EHRs was shown to be incomplete in 1
RAND Corporation study, with only one-third of the
parameters available (9), and not surprisingly, EHRs
at this time have not been found to signiﬁcantly
improve health care outcomes (10).
A data-guided health care system should lead the
way forward in improving patient outcomes in the
“real world.” This is perhaps why the data from the
Kaiser health care system and the Department of
Veterans Affairs can be so helpful to our under-
standing of contemporary imaging practices. These
health care systems have invested heavily in devel-
oping information technology systems that can guide
patient care and improve quality. In our futuristic
view, laboratories engaging in prudent imaging uti-
lization practices would be rewarded through per-
formance payments funded by reduced payments for
suboptimal imaging practices. We are just now envi-
sioning this world, where data guides our view of
“real-world” consumption patterns of cardiovascular
imaging.
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